Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss may indicate higher risk of heart disease.

Women with androgenetic alopecia may have higher blood pressure levels.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

COVID-19 can cause different skin symptoms that may help with early diagnosis and show how severe the disease is.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

COVID-19 can cause various skin lesions, which may result from the virus and immune response, and are not directly linked to illness severity.

Some birth control pills have a higher risk of blood clots than others.

Red, swollen skin patches are a common allergic reaction to heparin injections, and testing with different heparin types can help find a suitable treatment.

Tamoxifen effectively treats gynecomastia without causing impotence.

Minoxidil may cause heart issues in animals and humans.

Microencapsulation helps protect and track therapeutic cells, showing promise for treating various diseases, but more work is needed to improve the technology.

Some families have a genetic condition where they are born with irregular scalp defects.

A patient had skin tissue death at the hair removal site after a hair transplant, which was treated with surgery.

Lupus can look like hair loss from alopecia areata but needs different treatment.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

COVID-19 can cause various skin issues, including rashes and hair loss, which usually heal on their own and don't always indicate severe illness.

Looking at skin can help find and treat serious diseases early.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

Early treatment with immunoglobulin and aspirin reduces heart complications in children with Kawasaki disease.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

Australian doctors experienced in adult transgender healthcare mostly prescribe intramuscular testosterone and oral estradiol, recommend mental health assessments before hormone therapy, and support improved training and guidelines.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

Baricitinib and deuruxolitinib are effective for treating alopecia areata, but their efficacy depends on the dose.

Healthcare providers need better education and resources to give competent and sensitive care to transgender patients.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Careful management of blood thinners is crucial for lupus patients with APS.

The review found that COVID-19 can cause skin problems, including rashes and issues from wearing PPE, and suggests more research and protective measures for healthcare workers.

Finasteride, a hair loss medication, may be linked to stroke in young men.

The study found that prescribing patterns for Cyproterone Acetate/Ethinylestradiol in Italy did not significantly change after EMA recommendations.